(Hypertension. 2002;39:704.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology and Vascular Biology, Center of Excellence, College of Medicine (M.M.M., N.A.K., I.F.B., M.R.U., Z.K., A.E., K.U.M.), and the Department of Pathology (L.G., F.L.), The University of Tennessee, Baptist Memorial Hospital, Memphis, Tenn.
Correspondence to Kafait U. Malik, PhD, DSc, Professor of Pharmacology, Department of Pharmacology, College of Medicine, The University of Tennessee, Memphis, TN 38163. E-mail kmalik{at}utmem.edu
We have reported that norepinephrine (NE) and angiotensin II (Ang II) increase CaM kinase II activity, which, in turn, activates cytosolic phospholipase A2 (PLA2) and releases arachidonic acid. The products of arachidonic acid generated via cytochrome P-450 and lipoxygenase contribute to the development of hypertension and vascular smooth muscle cell (VSMC) hyperplasia. The purpose of this study was to investigate whether CaM kinase II contributes to VSMC proliferation elicited by NE and Ang II and to hypertension induced by Ang II. NE (1 µmol/L) and Ang II (1 µmol/L) increased proliferation of rabbit aortic VSMC as measured by increased [3H]-thymidine incorporation; this effect of NE and Ang II was attenuated 88±10% and 64±11% by the CaM kinase II inhibitor KN-93, respectively. Infusion of Ang II with miniosmotic pumps (350 ng/min for 6 days) in rats elevated mean arterial pressure (MABP), which was reduced by simultaneous infusion of KN-93 (578 ng/min, for 6 days) (Ang II alone: MABP =174±3 mm Hg, n=12 versus Ang II + KN-93: MABP 123±5 mm Hg, n=4, P<0.05). Administration of KN-93 as a single bolus injection (16 mg/Kg), but not its vehicle, in Ang IIinfused hypertensive animals also decreased MABP from 179±9 mm Hg to 109±6 mm Hg (n=5, P<0.05). CaM kinase II activity was increased in the kidney of Ang IIinfused hypertensive animals compared with normotensive controls. Treatment with KN-93 reduced CaM kinase II activity and ameliorated the intravascular injury in the kidneys of Ang IIinfused hypertensive rats. Our data indicate that CaM kinase activation represents an important component of the mechanism(s) initiating VSMC proliferation and the development and maintenance of Ang IIinduced hypertension in rat.
Key Words: kinase angiotensin II hypertension, essential muscle, smooth, vascular
This article has been cited by other articles:
![]() |
Z. Pavicevic, C. C. Leslie, and K. U. Malik cPLA2 phosphorylation at serine-515 and serine-505 is required for arachidonic acid release in vascular smooth muscle cells J. Lipid Res., April 1, 2008; 49(4): 724 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cai, D. Liu, and J. G.N. Garcia CaM Kinase II-dependent pathophysiological signalling in endothelial cells Cardiovasc Res, January 1, 2008; 77(1): 30 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Sucharov, S. Langer, M. Bristow, and L. Leinwand Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1029 - C1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gerzanich, S. Ivanova, M. S. van der Heijden, H. Zhou, and J. M. Simard Trans-Cellular Proliferating Cell Nuclear Antigen Gene Activation in Cerebral Vascular Smooth Muscle by Endothelial Oxidative Injury In Vivo Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2048 - 2054. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |